Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Esophageal Achalasia

Esophageal Achalasia

Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide (VIP)...

Gastrointestinal Motility Disorders

Gastrointestinal Motility Disorders

Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...

Myasthenia Gravis: Overview and Treatment

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...

Myasthenia Gravis ll: Pathophysiology

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...

Hiatal Hernia

Hiatal Hernia

A hiatal hernia is the abnormal protrusion of the stomach or other abdominal organs through the esophageal hiatus of the diaphragm into the thoracic cavity.Normally, the gastroesophageal junction (GEJ) lies below the diaphragm and is supported by the phrenoesophageal membrane, the diaphragmatic crura, and connective tissues. Weakening of these structures—due to aging, congenital defects like a short esophagus, or increased intra-abdominal pressure from coughing, obesity, pregnancy, or heavy...

Pyloric Obstruction

Pyloric Obstruction

Pyloric obstruction, also referred to as gastric outlet obstruction, is a condition characterized by narrowing or blockage at the pylorus—the muscular valve regulating the flow of stomach contents into the duodenum. When this passage becomes impaired, the stomach cannot effectively empty its contents into the small intestine. This disruption leads to a range of gastrointestinal symptoms, including early satiety, bloating, epigastric pain, postprandial nausea, persistent vomiting, and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Endocrine manifestations of chronic HCV infection.

Minerva endocrinologica·2015

Same author

Benefit of supplements in functional dyspepsia after treatment of Helicobacter pylori.

Minerva gastroenterologica e dietologica·2014

Same author

Inflammatory bowel diseases and primary sclerosing cholangitis: hepatic and pancreatic side effects due to azathioprine.

European review for medical and pharmacological sciences·2013

Same author

Ranitidine bismuth citrate in the first-line of Helicobacter pylori treatment.

Panminerva medica·2011

Same author

Amoxycillin plus tetracycline as first-line Helicobacter pylori treatment.

Minerva medica·2011

Same author

The diagnosis of gastroesophageal reflux disease.

Minerva gastroenterologica e dietologica·2007

Same journal

Hepatic steatosis integrated approach: nutritional guidelines and joined nutraceutical administration.

Minerva gastroenterologica e dietologica·2021

Same journal

Diagnostic accuracy of computerized tomography (CT) angiography in detecting non-variceal gastrointestinal bleeding (NVGIB): a sistematic review.

Minerva gastroenterologica e dietologica·2020

Same journal

Helicobacter pylori and non-alcoholic fatty liver disease.

Minerva gastroenterologica e dietologica·2020

Same journal

Hypertriglyceridemic pancreatitis.

Minerva gastroenterologica e dietologica·2020

Same journal

Effectiveness of percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis.

Minerva gastroenterologica e dietologica·2020

Same journal

Noninvasive diagnosis of fibrosis in non-alcoholic fatty liver disease: diagnostic accuracy of different scores.

Minerva gastroenterologica e dietologica·2020

See all related articles

Search research articles

Related Experiment Video

Updated: Jul 3, 2026

Robotic Myotomy and Partial Fundoplication for Achalasia

Robotic Myotomy and Partial Fundoplication for Achalasia

Published on: August 11, 2023

Achalasia.

L Dughera¹, P Cassolino, F Cisarò

¹Motility and Endoscopy Unit, Department of Internal Medicine, San Giovanni Battista Hospital, Turin, Italy. luca.dughera@libero.it

Minerva Gastroenterologica E Dietologica

|July 11, 2008

Summary

This summary is machine-generated.

Achalasia is a rare esophageal motility disorder causing difficulty swallowing and food retention. Current treatments aim to reduce lower esophageal sphincter pressure, offering palliative relief for this condition.

More Related Videos

Robotic Heller Myotomy for Advancements in Surgical Management of Achalasia

Robotic Heller Myotomy for Advancements in Surgical Management of Achalasia

Published on: February 16, 2024

Use of the Scissor-Type Knife During the Peroral Endoscopy Myotomy Procedure for the Treatment of Achalasia

Use of the Scissor-Type Knife During the Peroral Endoscopy Myotomy Procedure for the Treatment of Achalasia

Published on: March 3, 2023

Related Experiment Videos

Last Updated: Jul 3, 2026

Robotic Myotomy and Partial Fundoplication for Achalasia

Robotic Myotomy and Partial Fundoplication for Achalasia

Published on: August 11, 2023

Robotic Heller Myotomy for Advancements in Surgical Management of Achalasia

Robotic Heller Myotomy for Advancements in Surgical Management of Achalasia

Published on: February 16, 2024

Use of the Scissor-Type Knife During the Peroral Endoscopy Myotomy Procedure for the Treatment of Achalasia

Use of the Scissor-Type Knife During the Peroral Endoscopy Myotomy Procedure for the Treatment of Achalasia

Published on: March 3, 2023

Area of Science:

Gastroenterology
Esophageal Motility Disorders
Clinical Diagnosis and Management

Background:

Achalasia is a rare esophageal motor disorder characterized by absent peristalsis and impaired lower esophageal sphincter relaxation.
This leads to esophageal food stasis, causing symptoms like dysphagia, regurgitation, chest pain, and weight loss.
The exact etiology remains unknown, with limited evidence for genetic inheritance, though viral infections and autoimmune factors are being investigated.

Purpose of the Study:

To provide a comprehensive overview of achalasia, covering its pathophysiology, diagnostic approaches, and current therapeutic strategies.
To highlight the diagnostic gold standard and the roles of various imaging and endoscopic modalities.
To discuss the palliative nature of existing treatments for achalasia.

Main Methods:

Review of existing literature on achalasia pathophysiology, diagnosis, and treatment.
Emphasis on esophageal manometry as the gold standard for diagnosis.
Discussion of radiological studies and endoscopy in diagnosis and surveillance.
Analysis of current medical and surgical interventions.

Main Results:

Esophageal manometry is the definitive diagnostic tool, though its role in post-treatment surveillance is debated.
Radiology aids initial diagnosis and recurrence detection; endoscopy is crucial for excluding secondary causes.
Current treatments, including pneumatic dilation, myotomy, and medications, focus on reducing lower esophageal sphincter pressure.

Conclusions:

Achalasia is a complex esophageal motility disorder with unknown etiology.
Accurate diagnosis relies on esophageal manometry, supported by imaging and endoscopy.
Treatment is palliative, aiming to improve esophageal emptying and alleviate symptoms.